Skip to main content
. Author manuscript; available in PMC: 2008 Sep 2.
Published in final edited form as: Biochemistry. 2007 May 31;46(25):7572–7580. doi: 10.1021/bi700227g

FIGURE 6.

FIGURE 6

Western analysis of inhibition of PR protein expression by agLNAs of different designs. NT: no treatment control. All agLNAs are complementary to −9 to +10 relative to the transcriptional start site of PR–B. Percent inhibition is relative to the negative control treatment with LNAhcv